Welcome to our dedicated page for Prospect Capital SEC filings (Ticker: PSEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Prospect Capital Corporation (PSEC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents include current reports on Form 8-K, annual proxy statements on Schedule 14A and other materials that describe Prospect’s financial results, distributions, capital structure and governance.
Prospect uses Form 8-K to report material events such as quarterly and annual financial results, the declaration of monthly cash distributions to common shareholders, and dividends on its 5.35%, 5.50%, 6.50%, 7.50% and floating rate preferred stock series. These filings specify record dates, payment dates and dividend rates based on the stated value of the preferred shares. Form 8-Ks also describe institutional funding transactions, including the pricing and issuance of 5.5% Series A senior unsecured Notes due 2030, the key terms of the Deed of Trust governing those notes, and the expected listing of the notes and PSEC common stock on the Tel Aviv Stock Exchange.
Prospect’s definitive proxy statement on Schedule 14A outlines the agenda for its annual meeting of stockholders, including the election of directors, voting rights of common and preferred stockholders, and procedures for participating in virtual meetings. The proxy materials also discuss the company’s stockholder base, noting the significant presence of retail investors, and describe the use of a proxy solicitor to help achieve a quorum.
Through these filings, investors can review Prospect’s reported net investment income, net income or loss applicable to common shareholders, distributions, net asset value to common shareholders, leverage and coverage ratios, and portfolio composition, as summarized in the earnings press releases attached as exhibits. Filings also detail the company’s revolving credit facility, program notes, unsecured debt issuances and perpetual preferred stock programs.
On Stock Titan, AI-powered tools can help summarize lengthy PSEC filings, highlight key terms such as dividend declarations, new debt obligations and covenant descriptions, and make it easier to locate information about common and preferred stock, institutional notes and governance matters within Prospect Capital’s regulatory history.
Prospect Capital Corporation filed Post-Effective Amendment No. 118 to its Form N-2 registration statement (File No. 333-269714). The filing was made under Rule 462(d) solely to add and file exhibits and, per the company, does not modify any other part of the registration statement.
The amendment becomes effective immediately upon filing with the SEC. Prospect Capital is registered as a closed-end fund regulated as a business development company. The base registration contemplates securities that may be offered from time to time after effectiveness; this amendment is an administrative update limited to exhibits.
Prospect Capital Corporation announced it priced an institutional offering of approximately $167 million in aggregate principal amount of 5.5% Series A Notes due 2030. The Notes pay interest quarterly on March 31, June 30, September 30 and December 31, commencing March 31, 2026, and mature on December 31, 2030. They are general senior unsecured obligations, ranking equally with existing and future senior unsecured debt, and are rated ilAA- by S&P Global Ratings Maalot Ltd.
The offering is expected to close on October 30, 2025, with the Notes and the Company’s common stock expected to list and commence trading on the Tel Aviv Stock Exchange on November 2, 2025. The Company may redeem the Notes, in whole or in part, at any time after 60 days from the TASE listing at the greater of par plus accrued interest, the 30-day average closing price prior to board approval, or the discounted value of remaining payments. Net proceeds are expected to be used primarily to refinance existing indebtedness, including borrowings under the revolving credit facility, with any remainder for liquidity and investments consistent with its objectives.
Prospect Capital Corporation filed a preliminary pricing supplement for new Prospect Capital InterNotes, offering fixed-rate senior unsecured notes in three tranches: 6.250% Notes due 2028, 6.500% Notes due 2030, and 6.750% Notes due 2032, each sold at 100.000% of principal. The notes pay interest semi-annually on May 15 and November 15, starting May 15, 2026, with record dates on May 1 and November 1. Each series is callable at 100.000% beginning May 15, 2026, and includes a Survivor’s Option.
The trade date is November 3, 2025 with settlement on November 6, 2025. Minimum denominations are $1,000 and integral multiples thereof, DTC book-entry only. Notes will be sold through InspereX as Purchasing Agent, with agent concessions of 1.125% (2028), 1.700% (2030), and 1.950% (2032). In recent activity, the company repurchased $20.3 million aggregate principal of its 3.437% 2028 Notes at prices of 88.95%–89.95%, plus accrued interest.
Prospect Capital Corporation priced three new Prospect Capital InterNotes under its shelf, issuing fixed‑rate senior unsecured notes due 2028, 2030 and 2032. The tranches are: 6.250% Notes due 2028 with $415,000 principal, 6.500% Notes due 2030 with $74,000, and 6.750% Notes due 2032 with $52,000, each sold at 100.000% of principal.
Net proceeds are $410,331.25 (2028), $72,742.00 (2030) and $50,986.00 (2032) after selling concessions. Interest is paid semi‑annually on April 15 and October 15, beginning April 15, 2026. Each series includes a Survivor’s Option and is callable at 100.000% on April 15, 2026 and every business day thereafter, plus accrued interest.
The notes settle on October 30, 2025 in DTC book‑entry form and are issued under the existing 2012 Indenture, as further supplemented. Recent activity includes the repurchase of $20.3 million aggregate principal of the 3.437% 2028 Notes at 88.95%–89.95%, plus accrued interest.
Prospect Capital Corporation filed Post-Effective Amendment No. 117 to its Form N-2 registration statement (Reg. No. 333-269714). The filing, made under Rule 462(d), is solely to add exhibits and becomes effective immediately upon filing. It does not modify any other part of the registration statement.
The registration statement contemplates offerings “from time to time after the effective date.” This amendment consists of a facing page, an explanatory note, and Part C listing the exhibits, which are incorporated by reference.
Prospect Capital Corporation launched a primary offering of Prospect Capital InterNotes under its shelf, with three fixed-rate tranches: 6.250% Notes due 2028, 6.500% Notes due 2030, and 6.750% Notes due 2032. Each note pays interest semi-annually on April 15 and October 15, starting April 15, 2026, and is callable at 100% beginning April 15, 2026 and on any business day thereafter.
The notes will be sold at 100.000% of principal, with selling concessions of 1.125% (2028), 1.700% (2030), and 1.950% (2032). Minimum denomination is $1,000, DTC book-entry only. A Survivor’s Option applies as stated, allowing repayment at 100% of principal plus accrued interest, subject to annual aggregate and per-decedent limits.
Key dates include a trade date of October 27, 2025 and settlement on October 30, 2025. Recent activity noted a repurchase of $20.3 million aggregate principal of the 3.437% 2028 notes at prices between 88.95% and 89.95%, plus accrued interest.
Prospect Capital Corporation priced three Prospect Capital InterNotes under its 424(b)(2) program: 6.250% Notes due 2028 ($189,000 principal), 6.500% Notes due 2030 ($135,000), and 6.750% Notes due 2032 ($55,000). Each series priced at 100% of principal with semi-annual interest and first coupons on April 15, 2026.
The 2028 Notes carry a 1.125% gross concession with net proceeds of $186,873.75; the 2030 Notes carry a 1.700% gross concession with net proceeds of $132,705.00; the 2032 Notes carry a 1.950% gross concession with net proceeds of $53,927.50. All are unsecured senior obligations with a Survivor’s Option and are callable at 100% on April 15, 2026 and thereafter, plus accrued interest.
Trade date was October 20, 2025, with settlement on October 23, 2025, $1,000 minimum denomination, DTC book-entry. Recent activity disclosed a repurchase of $20.3 million aggregate principal of 3.437% 2028 Notes at 88.95%–89.95%, plus accrued interest.
Prospect Capital Corporation filed Post-Effective Amendment No. 116 to its Form N-2 registration statement (Registration No. 333-269714). The filing was made under Rule 462(d) solely to add exhibits and became effective immediately upon filing.
The amendment consists of a facing page, an explanatory note, and Part C listing exhibits, and it does not modify any other part of the registration statement. The registration statement continues to permit offerings from time to time after the effective date.
Prospect Capital Corporation (PSEC) filed Post-Effective Amendment No. 115 which records corporate housekeeping details including entities it controls as of
M. Grier Eliasek, Chief Operating Officer and Director of Prospect Capital Corp (PSEC), reported an open-market purchase of 370,000 shares of common stock on 09/25/2025 at a price of $2.71 per share. After the transaction the reporting person beneficially owned 2,501,130.422 shares. The Form 4 was signed on 09/29/2025.
FAQ
What is the current stock price of Prospect Capital (PSEC)?
What is the market cap of Prospect Capital (PSEC)?
